BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28901496)

  • 1. High CCL5 expression is associated with osteosarcoma metastasis and poor prognosis of patients with osteosarcoma.
    Sun K; Gong C; Peng H; Fang H; Zhou J; Li J; Chen S; Zheng H
    Mol Med Rep; 2017 Nov; 16(5):6953-6957. PubMed ID: 28901496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
    Zhu Y; Zhou J; Ji Y; Yu B
    Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
    Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
    Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XB130 expression in human osteosarcoma: a clinical and experimental study.
    Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
    Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of MMP-2 expression and prognosis in osteosarcoma patients.
    Zhang M; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic relevance of centromere protein A in primary osteosarcoma.
    Gu XM; Fu J; Feng XJ; Huang X; Wang SM; Chen XF; Zhu MH; Zhang SH
    Pathol Res Pract; 2014 Apr; 210(4):228-33. PubMed ID: 24440098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
    Zhao C; Li H; Wang L; Sun W
    Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis.
    Liang S; Ren Z; Han X; Yang J; Shan L; Li L; Wang B; Zhang Q; Mu T; Chen K; Xiong S; Wang G
    PLoS One; 2015; 10(5):e0127236. PubMed ID: 25993412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
    Tian ZZ; Guo XJ; Zhao YM; Fang Y
    Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma.
    Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Leptin and Sirtuin-1 is associated with poor prognosis in patients with osteosarcoma.
    Feng H; Guo P; Wang J; Xu J; Xie C; Gao F
    Pathol Res Pract; 2016 Apr; 212(4):319-24. PubMed ID: 26936024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.